Revium Rx (RVRC) Gains from Investment Securities (2024 - 2025)
Revium Rx recorded quarterly Gains from Investment Securities of $690000.0 in Q4 2025, down 6.76% quarter-over-quarter from $740000.0 in Q4 2024, and down 6.76% year-over-year from $740000.0 in Q4 2024.
Revium Rx's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $690000.0 for Q4 2025.
- In Q4 2025, Gains from Investment Securities fell 6.76% year-over-year to $690000.0; the TTM figure through Dec 2025 stood at $690000.0 (down 6.76% YoY), while the FY2025 annual figure was $690000.0, down 6.76% from the prior year.
- Gains from Investment Securities came in at $690000.0 for Q4 2025 at Revium Rx, down from $740000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $740000.0 in Q4 2024 to a low of $690000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Revium Rx | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 690,000.00 |
| Dec 31, 2025 | 690,000.00 |
| Dec 31, 2024 | 740,000.00 |
| Dec 31, 2024 | 740,000.00 |